ONCY is partners with the following:
1- The National Cancer Institute (who is sponsoring 8 of their 14 ongoing trials).
2- The various Chemo companies whose chemo is an adjuvant to Reolysin in treatment of cancer.
3- The Radiation Industry who provide an adjuvant therapy to make REO effective.
4-The FDA who is partners with the NCI in pushing new,novel ,safe, effective therapies thru to the public.
With all of these partners on their side who can be against ONCYs REOLYSIN?
Who would dare prevent the public from this big step in the war against cancer?
It is a win/win situation for all. Imagine the saving of lives around the world .
Rarely have we seen an opportunity like this for all to prosper.
Excellent summary of an additional, must-consideration. The partnerships weigh heavily in ONC/ONCY's favor. Also, do not forget the patents. An impressive list that could easily be worth as much REO sales. Big pharma must be just as interested in the patents as they are REO.